Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-20-028410

EVP, Research & Development sold 1,500 shares at $350.00 ($525,000)

From the SEC's structured data for this filing

Trades in this filing

Sandrock Alfred · EVP, Research & Development

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-04 Sale : show line 1 in the form −1,500 $350.00 $525,000 13,066.21 D
Open-market sales · 1,500 sh · avg $350.00 · $525,000
Loading xslF345X03/form4.xml…